Abate As Industries Ltd

Abate As Industries Ltd, a micro-cap player in the hospital sector, has seen its investment rating upgraded from Strong Sell to Sell as of 18 March 2026. This change reflects a nuanced shift in the company’s technical outlook amid persistent fundamental weaknesses, prompting a reassessment of its risk and return profile by analysts.

Abate As Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 February 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 12 March 2026, providing investors with the latest comprehensive analysis.

Abate As Industries Ltd, a player in the hospital sector, has seen its investment rating downgraded from Sell to Strong Sell as of 24 February 2026, reflecting deteriorating technical indicators, expensive valuation metrics, and weak long-term fundamentals despite recent positive quarterly financial results.

Abate As Industries Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting significant improvements in its financial performance and technical outlook. Despite lingering concerns over valuation and long-term fundamentals, the company’s recent quarterly results and market behaviour have prompted a reassessment of its prospects.

Abate As Industries Ltd, a key player in the hospital sector, has demonstrated a marked improvement in its financial performance for the quarter ended December 2025. The company’s latest results reveal record-high net sales and operating profits, signalling a significant turnaround in its financial trend and offering a fresh perspective for investors amid a challenging market backdrop.

Abate As Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 13 February 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Abate As Industries Limited, a micro-cap hospital sector player with a market capitalisation of ₹218.00 crores, has delivered a stunning operational turnaround in Q3 FY26, posting consolidated net profit of ₹3.06 crores—a dramatic reversal from losses in the previous year. However, this impressive operational performance is overshadowed by a troubling valuation picture, with the stock trading at an eye-watering 189x trailing earnings and earning a "STRONG SELL" rating with a score of just 27 out of 100.

Abate As Industries Ltd, a player in the hospital sector, has seen its investment rating downgraded from Sell to Strong Sell as of 1 February 2026. This revision reflects a deterioration in technical indicators, valuation concerns, and weak financial trends despite some positive quarterly results. The company’s Mojo Score now stands at a low 27.0, signalling significant caution for investors.

Abate As Industries Ltd is rated Sell by MarketsMOJO, with this rating last updated on 31 December 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 23 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Abate As Industries Ltd is rated Sell by MarketsMOJO, with this rating last updated on 31 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Abate As Industries Ltd, a player in the hospital sector, has seen its investment rating downgraded from Hold to Sell as of 31 December 2025. This change reflects a combination of deteriorating technical indicators, expensive valuation metrics, weak financial trends, and overall low quality scores, signalling caution for investors despite some recent positive quarterly results.

Abate As Industries, a player in the hospital sector, has experienced a notable shift in its market evaluation, reflecting a complex interplay of technical trends, valuation metrics, financial performance, and broader market context. This article analyses the factors influencing the recent revision in the company’s assessment, providing investors with a comprehensive understanding of its current standing.

Abate As Industries, a player in the hospital sector, has undergone a recent revision in its market assessment, reflecting nuanced shifts across key evaluation parameters including quality, valuation, financial trends, and technical indicators. This article examines the underlying data and market context shaping the current perspective on the stock.

Abate As Industries, a player in the hospital sector, has experienced a notable revision in its market evaluation, reflecting a complex interplay of technical momentum, valuation considerations, financial trends, and quality metrics. This article analyses the factors influencing the recent shift in the company’s assessment and what it means for investors navigating the hospital industry landscape.

Abate As Indust, a microcap player in the hospital sector, has undergone a revision in its market evaluation reflecting a nuanced shift in its financial and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, providing investors with a clearer perspective on its current standing.

Abate As Industries Ltd, a player in the hospital sector, is currently experiencing significant selling pressure with no buyers in the queue, signalling distress selling and a challenging market environment. The stock has recorded consecutive losses over the past four days, reflecting a notable shift in investor sentiment.

Abate As Industries Ltd, a key player in the hospital sector, is currently experiencing significant selling pressure, with only sell orders queued on the trading day. This extreme market behaviour signals distress selling and a lack of buyer interest, contrasting sharply with broader market trends and raising concerns about the stock's near-term outlook.